Antisense and RNAi Therapeutics Market (Updated Version Available)

The report offers detailed coverage of Antisense and RNAi Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Antisense and RNAi Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene "off".

The report forecast global Antisense and RNAi Therapeutics market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2028.

First, this report covers the present status and the future prospects of the global Antisense and RNAi Therapeutics market for 2015-2028.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.


At the same time, we classify Antisense and RNAi Therapeutics according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market by Order Type
RNA interference
SiRNA
MiRNA
Antisense RNA

Market by Application
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Antisense and RNAi Therapeutics market for the forecast period 2020 - 2028?
• What are the driving forces in the Antisense and RNAi Therapeutics market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Antisense and RNAi Therapeutics industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?